The global sustainable packaging market is expected to expand at a CAGR of 8.5% during the forecast period of 2025 to 2033. The market expansion is attributable to the government's stringent laws on sustainable development and the packaging industry's rising need for recycled packaging materials. The production and use of packaging that enhances sustainability are referred to as sustainable packaging.
The global market for monkeypox vaccines and treatments is anticipated to expand at a compound annual growth rate (CAGR) of 11% during the forecast period of 2025 to 2033. The market is anticipated to be driven by factors such as the increasing incidence of monkeypox infection across the globe and the rising demand for treatment and prevention methods. Bavarian Nordic A/S, for example, announced in July 2025 that it had received an additional order for 2.5 million doses of JYNNEOS from the U.S. BARDA.
Despite advances in treatment, the high morbidity and death rate of heart failure is driving the global absorbable antibacterial envelope market. Mortality in individuals with heart failure is not only caused by hemodynamic failure; ventricular arrhythmias might also be to blame. In the coming years, the use of implantable cardioverter defibrillators (ICDs) to reduce arrhythmic sudden fatalities is anticipated to boost the market. Moreover, cardiac resynchronization therapy (CRT) is another promising treatment option for heart failure patients.
The rare kidney disease treatment market is expected to expand at a CAGR of 6% during the forecast period of 2025 to 2033 The global market for rare kidney disease treatment market was valued at US$ 2.5 Bn in 2021. The occurrence of acute renal failure and other kidney illnesses that are relatively uncommon is on the rise dramatically around the world. Rare kidney illnesses have only a limited number of therapeutic options that have been approved.
The global market for rheumatoid arthritis treatments is expected to grow at a CAGR of 5% during the forecast period of 2025 to 2033. Rheumatology is the branch of internal medicine that deals with the diagnosis and treatment of rheumatic illnesses. Rheumatic disorders are characterized by joint, tendon, ligament, bone, and even organ inflammation. These conditions are commonly known as musculoskeletal illnesses and are characterized by significant pain, deformity, and morbidity.
The global market for hyperpigmentation disorder treatment was worth US $4.5 billion in 2021. It is anticipated that the global market will advance at a CAGR of 9% during the forecast period of 2025 to 2033. By the end of 2033, it is estimated that the global market for the treatment of hyperpigmentation disorders would have reached over US $10 billion.
The hazelnut market is expected to expand at a CAGR of 10.2% during the forecast period of 2025 to 2033. It is anticipated that increased awareness regarding the health benefits of consuming hazelnuts would drive enormous demand potential in the global hazelnut market throughout the period forecast from 2020 to 2033.
The water and wastewater treatment market is expected to grow at a CAGR of 7.5% during the forecast period of 2025 to 2033. The global COVID-19 epidemic has been unprecedented and astounding, resulting in a demand for water and wastewater treatment that is lower than anticipated across all regions when compared to levels that existed prior to the pandemic. The growth of the water and wastewater treatment equipment market is likely to be driven during the forecast period by the rising demand for water and wastewater treatment equipment in municipal and industrial applications.
The global market for textile auxiliaries is expected to grow at a CAGR of 5% during the forecast period of 2025 to 2033. Demand for textile auxiliaries is being fuelled across the world by a number of factors, including the expansion of the global apparel and clothing industry, the growing utilisation of textile auxiliaries for a variety of applications, and the shifting emphasis toward environmentally friendly products. By the end of 2025, the global market for textile auxiliaries will account for approximately 40% of the total value of the textile chemicals industry.
In 2020, the global market for insomnia was estimated to be worth US $4.5 billion and is expected to grow at a CAGR of 6.2% during the forecast period of 2025 to 2033. It is anticipated that the strong demand will be fuelled by an increase in the launch of novel products over the course of the forecast period, the availability of a number of generic alternatives, increasing prevalence of insomnia and stressare the key factors that aredriving the growth of insomnia therapies market.
The drugs by therapeutic area include therapy for oncology, cardiovascular, central nervous system, infectious diseases, respiratory, and others. The therapeutic area represents the specific area of medicine where the drug is intended to be used, based on its mechanism of action and intended clinical use. One of the primary drivers of the drugs by therapeutic area market is the increasing prevalence of diseases worldwide. Chronic diseases such as cancer, cardiovascular diseases, and neurological disorders are a significant burden on healthcare systems globally. There is an urgent need for new and effective therapies to treat these diseases, which has led to the growth of the drugs in the therapeutic area market.
The revenues generated by the drugs in the therapeutic area market have been consistently high over the years. The global pharmaceutical market is expected to reach USD 1.5 trillion by 2023, with oncology being the leading therapeutic area. The increasing demand for new therapies, coupled with advancements in technology and an increasing focus on personalized medicine, is expected to drive the growth of the market in the coming years. One of the emerging trends in the drugs by therapeutic area market is the increasing use of precision medicine. Precision medicine involves tailoring medical treatments to individual patients based on their unique genetic and molecular profiles. The development of precision medicine requires the use of advanced diagnostic tools and drug discovery technologies, which have contributed to the growth of drugs in the therapeutic area market.
Another trend in the drugs by therapeutic area market is the increasing focus on biologics. Biologics are drugs that are produced from living cells and are used to treat a wide range of diseases, including cancer and autoimmune disorders. Biologics are more complex than traditional small-molecule drugs, and their development requires specialized manufacturing processes and clinical trial design. The increasing demand for biologics has contributed to the growth of the drugs by therapeutic area market. The increasing focus on rare diseases is also driving the growth of the drugs by therapeutic area market. Rare diseases are defined as diseases that affect fewer than 200,000 people in the United States. Although each rare disease affects a small number of people, there are over 7,000 rare diseases, which together affect millions of people worldwide. There is an urgent need for new therapies to treat rare diseases, which has led to the growth of drugs in the therapeutic area market.
The increasing use of combination therapies is driving the growth of the drugs by therapeutic area market. Combination therapies involve the use of two or more drugs to treat a disease. Combination therapies can improve patient outcomes by targeting multiple pathways involved in the disease process. The development of combination therapies requires the use of advanced drug discovery technologies and clinical trial design, which has contributed to the growth of the drugs by therapeutic area market. The increasing prevalence of diseases worldwide, advancements in technology, and the emerging trends in precision medicine, biologics, rare diseases, and combination therapies are expected to drive the growth of the drugs by therapeutic area market.
